Renalytix plc
RNLXYOTCHealthcare · Services-Medical Laboratories · X0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | |
|---|---|---|---|
| Revenue | $2.3M | $100,000 | $3.0M |
| Operating income | −$29.6M | −$42.2M | −$53.2M |
| Net income | −$33.5M | −$45.6M | −$45.3M |
| Total assets | $8.0M | $30.6M | $50.1M |
| Total liabilities | $15.8M | $23.7M | $19.5M |
| Equity | −$7.9M | $7.0M | $30.6M |
| EPS (diluted) | $-0.31 | $-0.55 | $-0.67 |
| Shares out. | 165.9M | 95.0M | 74.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −1293.5%
- Net margin
- −1461.6%
- Return on equity
- 426.0%
- Return on assets
- −419.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 198.5%
- Debt / equity
- —
- Book value / share
- $-0.05
- Revenue growth (YoY)
- 2189.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -116.51distress
- Accruals / assets
- −42.0%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 14, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Jefferson River Capital LlcActivist (13D)Feb 23, 2026
- Ubs Group AgPassive (13G)Apr 30, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 25,191 | 9.9 | +15.8% |
| Apr 30, 2026 | 21,758 | 7.2 | +10.7% |
| Apr 15, 2026 | 19,662 | 2.1 | +5912.8% |
| Mar 31, 2026 | 327 | 1.0 | -51.8% |
| Mar 13, 2026 | 679 | 1.0 | -63.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureJan 16, 2025
- Shareholder vote · Regulation FD disclosureDec 20, 2024
- Director / officer change · Shareholder vote · Regulation FD disclosureNov 6, 2024
- Entered a material agreement · Completed an acquisition or disposition · Results of operations · New financial obligation · Delisting / listing-standard notice · Unregistered equity sale · Other material eventOct 1, 2024
- Delisting / listing-standard notice · Regulation FD disclosureAug 27, 2024
- Unregistered equity sale · Regulation FD disclosureJul 15, 2024
- Delisting / listing-standard noticeJun 24, 2024
- Changed auditorJun 24, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13D/AFeb 23, 2026
- F-6 POSDec 3, 2025
- F-6 POSSep 4, 2025
- EFFECTJul 30, 2025
- EFFECTJul 30, 2025
- EFFECTJul 30, 2025
- EFFECTJul 30, 2025
- EFFECTJul 30, 2025
- 424B3Jul 30, 2025
- 15-12GFORM 15-12GJul 30, 2025
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3Jul 29, 2025
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3Jul 29, 2025
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3Jul 29, 2025
- POS AMPOST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-3 ON FORM S-3Jul 29, 2025
- POS AMPOST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-3 ON FORM S-3Jul 29, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.